Because RPL10 ufmylation was associated with PAAD development and originally reported in E14 embryotic stem cells [12], it was reasonable for us to hypothesize that RPL10 ufmylation might be related to the proliferation and stemness of pancreatic cancer cells for tumor development. The gene discussed is RPL10; the disease is neoplasm.